Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „further“
Suchtreffer
Begriffe & Kennungen
Spedra · 4.5 · Since the in vitro data identified potential avanafil interactions with CYPs 2C19, 2C8/9, 2D6 and 3A4, further
Eintrag öffnenSpedra · 4.5 · Since the in vitro data identified potential avanafil interactions with CYPs 2C19, 2C8/9, 2D6 and 3A4, further
Eintrag öffnenSpedra · 4.5 · Since the in vitro data identified potential avanafil interactions with CYPs 2C19, 2C8/9, 2D6 and 3A4, further
Eintrag öffnenSuboxone · 4.5 · • Furthermore, adequate analgesia may be difficult to achieve when administering a full opioid agonist in pati
Eintrag öffnenSuboxone · 4.5 · • Furthermore, adequate analgesia may be difficult to achieve when administering a full opioid agonist in pati
Eintrag öffnenTarceva · 4.8 · Second and Further Line Treatment
Eintrag öffnenTecentriq · 4.8 · Further details on serious adverse reactions are provided in section 4.4.
Eintrag öffnenTecentriq · 4.8 · Further details on serious adverse reactions are provided in section 4.4.
Eintrag öffnenTelmisartan Actavis · 4.8 · 1,2,3,4: for further descriptions, please see sub-section ”Description of selected adverse reactions”.
Eintrag öffnenTelmisartan Teva Pharma · 4.8 · : for further descriptions, please see sub-section ”Description of selected adverse reactions”. 1, 2, 3, 4
Eintrag öffnenTevagrastim · 4.8 · There is insufficient data to further evaluate filgrastim use in paediatric subjects.
Eintrag öffnenTolura · 4.8 · 1, 2, 3, 4: for further description, please see sub-section “Description of selected adverse reactions”
Eintrag öffnenTovanor Breezhaler · 4.8 · The safety profile is further characterised by other symptoms related to the anticholinergic effects, includin
Eintrag öffnenTrecondi · 4.8 · One of 613 adult patients (0.2%) developed a second malignancy (breast cancer). A few further cases of second
Eintrag öffnenTruxima · 4.8 · Re-treatment The percentage of patients reporting adverse reactions upon re-treatment with further courses of
Eintrag öffnenTybost · 4.5 · Consult the Summary of Product Characteristics of atazanavir or darunavir for further information on use in co
Eintrag öffnenVpriv · 4.8 · 5 further information). The only adverse reaction leading to discontinuation of treatment was an infusion-rela
Eintrag öffnenWakix · 4.5 · With oral contraceptives, the combination with pitolisant should be avoided and a further reliable contracepti
Eintrag öffnenXigduo · 4.8 · Further evaluation of patients who had renal-related adverse events showed that most had serum creatinine chan
Eintrag öffnenXolair · 4.8 · Immune system disorders For further information, see section 4.4.
Eintrag öffnen